Past HCCdays

29.11.2018

14:00-14:30 Dr. Nicolas Goossens (Genève Hôspital, CH-Geneve) Surveillance. The case of NAFLD
14:30-15:00 PD Dr. Vanessa Banz (Inselspital, CH-Bern) De novo or salvage Tx
15:00-15:30 Dr. Alessandro Vitale (Padua University Hospital, Italy) Tumor Burden and prognosis
15:30-16:00   Pause
16:00-16:30   Recipient Price
16:30-17:00 Dr. Vincent Donckier (Institut Jules Bordet,Brussels, Belgium) SIRT and resection
17:00-17:30 Prof. Sandrine Faivre (HUPVNS, Paris, France) New systemic treatments
17:30-17:45 Prof. Dufour, Head of Hepatology Department, University Hospital of Berne Closing remarks
17:45-19:00   Apéro

01.09.2017

14:00-14:30 Prof. Pierre Nahon, Hôpital Jean Verdier Bondy, Paris HCC surveillance after Hepatitis C
14:30-15:00 Prof. Christian Toso, HUG Genève Listing for transplantation patients with HCC
15:00-15:30 Prof. Philip Johnson, University of Liverpool Pre-radiology HCC
15:30-16:30   Pause
16:30-17:00   Presentation of the prize winner
17:00-17:30 Dr. Anja Lachenmayer, Inselspital Microwave ablation for HCC
17:30-18:00 Prof. Chris Verslype, KU Leuven New systemic therapies (incl. Comparison with SIRT)
18:00-18:15 Prof. J.-F. Dufour, Head of Hepatology Department, University Hospital of Berne Closing remarks
18:15-19:15   Apéro

03.11.2016

14:00-14:30 E. Giannini Surveillance. The case of NAFLD
14:30-15:00 P. Dutkowski De novo or salvage Tx
15:00-15:30 F. Blanc Immunotherapy to treat HCC
15:30-16:30   Pause
16:30-17:00   Presentation of the prize winner
17:00-17:30 A. Denys Get the maximum out of SIRT
17:30-18:00 M. Reigs New treatments of HCV and HCC
18:00-18:15 Dufour Closing remarks

17.01.2015

13:30-14:00 Dufour Jean-François Bern HCC cohort
14:00-14:30 M. Heim Transcriptomics of HCC
14:30-15:00 Augusto Villanueva Biomarkers-driven therapy
15:00-15:30 Markus  
15:30-16:00   Coffeebreak
16:00-16:30 Sandrine Faivre Second line therapy
17:00-17:30 Golfieri TACE: Who, When, How?
17:30-18:00 Pierre Nahon Metabolomic for HCC

18.09.2014

13:00-13:30   Welcome
13:30-13:35 Prof. Denys/ Prof. Raymond Transcriptomics of HCC
13:35-14:30 Prof. P. Majno/ Prof. A. Denys Early HCC – What is the best primary option?
14:30-15:30 Prof. J.-F. Dufour/ Dr. S. Terraz Intermediate stage – TACE: Who, when, how and how to evaluate response
15:45-16:15   Coffeebreak
16:15-17:15

Prof. J. Ricke

Dr. S. Faivre

Advanced stage, Update on trials on radio-embolization as a stand-alone or in combination
with systemic therapy

Future developments in systemic therapy

17:30-18:30   Farewell Apéro

17.01.2013

13:30-14:00 Dufour Jean-François HCC Kohorte
14:00-14:30 Breitenstein Stefan Resection
14:30-15:00 Fuks David Transplantation
15:00-15:30 Verslype Chris Systemic therapy
15:30-16:00   Coffeebreak
16:00-16:30 Meyer Tim Combination therapy
17:00-17:30 Semela David Angiogenic biomarkers
17:30-18:00 Denys Alban Internal radiotherapy

20.10.2011

14:00-14:25 Dr. med. Jean-Luc Raoul, Rennes Cedex, France Combinated TACE – Sorafenib
14:25-14:50 Dr. med. Sylvain Terraz, Geneve, Schweiz Radiofrequency ablation
14:50-15:15 Dr. med. Michael Montemurro, Lausanne, Schweiz Tyrosine kinase inhibitors
15:15-15:30   Case 1 discussion
16:00-16:30   Pause
16:30-16:55 Dr. med. Fabio Piscaglia, Bologna, Itally Downstaging
16:55-17:20 Dr. med. Markus Heim, Basel, Schweiz Viral hepatitis and HCC
17:20-17:45 Prof. Dr. med. Daniel Candinas, Inselspital Bern, Schweiz Resection
17:45-18:00   Case 2 discussion

 

11.11.2010

14:00-14:25 B. Muellhaupt Effect of screening on therapeutic options
14:25-14:50 B. Sangro Radioembolisation for HCC
14:50-15:15 J Kettenbach DC beads
15:15-15:30 J-F Dufour Case 1 discussion
16:00-16:30   Pause
16:30-16:55 D. Köberle Sorafenib alone or in combination
16:55-17:20 R. Bale Get the maximum out of RFA
17:20-17:45 C. Toso How to prevent recurrence after transplantation for HCC?
17:45-18:00 B.Pestalozzi, P. Samaras Case 2 discussion